Last reviewed · How we verify

NCT06623097: VITALITY

Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study

Recruiting now NA Last updated 2 March 2026
What this trial tests

NA trial testing Supervised Exercise and Diet Program in Cancer Survivorship in 1,528 participants. Currently enrolling.

Timeline
23 July 2025
Primary endpoint
30 April 2029
30 April 2030

Quick facts

Lead sponsorDana-Farber Cancer Institute
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment1,528
Start date23 July 2025
Primary completion30 April 2029
Estimated completion30 April 2030
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Dana-Farber Cancer Institute

Who can join

18 and older, any sex, with Cancer Survivorship. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research study will compare the impact of virtually supervised and unsupervised home-based exercise and diet programs on cognitive and physical function among cancer survivors and support persons. This study will involve a 6-month home-based virtually supervised or unsupervised exercise and diet intervention. The names of the study interventions involved in this study are: * Virtually supervised exercise and healthy diet care * Unsupervised exercise and healthy diet care

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer Survivorship

Currently open trials in the same condition.

Other Dana-Farber Cancer Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06623097.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing